Original ResearchPublished 12 October 2026Taxifolin alleviates podocyte injury and macrophage chemotaxis associated with diabetic nephropathy by directly targeting RBP1 identified via multi-omics and machine learningZi-Xuan Wang · Wen-Xuan Wang · Qiong-Dan Liang · Ling-Dong KongFrontiers in Pharmacologydoi 10.3389/fphar.2026.1933167